| News

Aging: The Tsunami for Healthcare

27.02.2019

Humanity is growing older. According to the UN the number of people in the world aged 60 years or over is projected to double to 2.1 billion by 2050. In developed countries, more than one third of the population will be over 60 by this time. The number of people over 80 will increase even faster to 434 million from 125 million in 2017. Meanwhile the working age population, who are needed to pay or provide support for the elderly, will only increase by about 25 percent over the same time.

From the left side: Thomas Brenzikofer (DayOne/ BaselArea.swiss), Szofia Bullain (MD Geriatric Neurologist), Antonella Santuccione (Woman’s Brain Project and Roche Diagnostics), Hansruedi Voelkle (EUPATI), Manfred Eggersdorfer, (DSM Nutritional Products), Andy Bushell (Novartis), Mieke Deschodt (University of Basel)

These numbers make clear: The question mark in the title of the DayOne Experts Event “Aging – the game changer for healthcare?” is actually redundant. The game simply has to be changed! The speakers and panelists at the event that took place in Basel on February 26 agreed that healthcare as we know it will not be able to cope with the tsunami of aging. Under this perspective, aging not only represents a threat, but also an opportunity, for it will compel the industry to make the systematic changes that are required for the overall improvement of healthcare. Therefore aging can and should also be perceived as an interesting market for healthcare innovation.

But where to begin? This is what we learned from the speakers and panelists at the DayOne Expert Event:

1) Healthcare as we know it has been built for acute care: from infrastructure to career plans, research incentives and reimbursement schemes, healthcare professionals are trained to fix and rescue lives. But when it comes to long-term care and treatment this acute system is highly inefficient and costly. A possible way forward was presented by Mieke Deschodt from the University of Basel, who presented the novel care concept INSPIRE, which will be implemented in the canton of Baselland.

2) A big research effort is needed to better diagnose, treat and most of all prevent the disease burdens of an aging population. As Antonella Santuccione from the Woman’s Brain Project stated: It takes weeks to diagnose a tumor, but years to diagnose Alzheimer’s. And the significant differences in disease progression in terms of gender shows that a precision medicine approach is very much needed to make progress in treating disorders that are typical to aging.

3) The best way to cope with the tsunami of aging is actually by staying healthy – not only as long as possible but preferably to the end of life. In this perspective, we have to shift our mindset from neglecting or avoiding aging to aging successfully. And as the findings of the 90+ Study show, presented by geriatric neurologist Szofia Bullain, this will need a more holistic view on health, as psychological and social implications seem to count much more than physical activities and healthy nutrition alone for successful aging.

4) The right use and bold implementation of technology, most of all digital technology, will be crucial. But a lifelong approach will also be needed. Knowing the genetic preposition would allow for better monitoring and nudging an individual to healthy behavior, thereby preventing the occurrence of disease in old age starting from the very beginning of our lifespan. But to actually make this happen a first important step will be to set up a trusted platform which allows citizens to share their health data with all stakeholders.

A big thank you to all the speakers and panelists for sharing their great stories and very valuable insights:

Mieke Deschodt, University of Basel
Antonella Santuccione, Woman’s Brain Project and Roche Diagnostic
Szofia Bullain, MD Geriatric Neurologist
Manfred Eggersdorfer, DSM Nutritional Products
Andy Bushell, Novartis
Hansruedi Voelkle, EUPATI

Impressions

Slides presented at the Event

Presentation by Antonella Santuccione from Woman’s Brain Project and Roche Diagnostic

Presentation by Mieke Deschodt from the University of Basel

Presentatio by Szofia Bullain from MD Geriatric Neurologist

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Innovation

docdok.health involved in coronavirus research project

A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.

Read More
Basel Area Business & Innovation, Innovation

Celonic agrees cooperation to combat coronavirus

The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two companies are planning to develop a drug to treat coronavirus.

Read More
Basel Area Business & Innovation, Innovation, Invest

Idorsia receives payment of 45 million US dollars

The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..

Read More
Basel Area Business & Innovation, Innovation

Humard robot disinfects using UV light

Humard has developed a robot that can disinfect spaces using UV light. For this, the system manufacturer from the canton of Jura has adapted a mobile industrial robot that is otherwise used in warehouse logistics.

Read More
Basel Area Business & Innovation, Innovation, Invest

Roche authorized to distribute coronavirus antibody tests

Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.

Read More
Basel Area Business & Innovation, Invest

Basel is the most popular Swiss location for headquarters

Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.

Read More
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Healthtech sector growing rapidly in the Basel Area

The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.

Read More
Basel Area Business & Innovation, Innovation, Invest

Support program has roots in Basel

The online program Selfapy supports people suffering from mental health conditions during the coronavirus lockdown. BaselArea.swiss has provided startup help by way of its DayOne initiative.

Read More
Basel Area Business & Innovation, Innovation

University Hospital Basel treats coronavirus patients with plasma

The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.

Read More
Basel Area Business & Innovation, Innovation

Botnar Research Center advancing research into coronavirus

The Basel-based Botnar Research Center for Child Health is providing capital in the amount of 15 million Swiss francs to its four partner institutions. In this way, the University of Basel should be in a position to advance research into dealing with the coronavirus outbreak.

Read More
1 2 3 18

Do you have a question? We'd like to hear from you.